Anne S. de Groot
Directeur Général chez EpiVax, Inc.
Profil
Anne S.
de Groot is the founder of EpiVax, Inc. (founded in 1998) and GAIA Vaccine Foundation (founded in 2002).
She currently holds positions as the Director at Epivax Oncology, Inc., Professor at Brown University, and Professor at the University of Rhode Island (since 2013).
Dr. de Groot completed her undergraduate degree at Smith College in 1978 and obtained her doctorate degree from The University of Chicago in 1983.
Postes actifs de Anne S. de Groot
| Sociétés | Poste | Début |
|---|---|---|
EpiVax, Inc.
 EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Directeur Général | 01/01/1998 |
| Brown University | Corporate Officer/Principal | - |
| University of Rhode Island | Corporate Officer/Principal | - |
| GAIA Vaccine Foundation | Fondateur | 01/01/2002 |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Formation de Anne S. de Groot
| Smith College | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
| GAIA Vaccine Foundation | |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
